Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapies

Fig. 5

Histotype influence on drug response. a-b P values for pairwise F-tests between histotype IC50 for Bleomycin (a) and Vorinostat (b). c-d Measured vs Predicted IC50 using DEGs for Bleomycin (c) and Vorinostat (d). e-f Measured vs. Predicted IC50 for Hist models in Bleomycin (e) and Vorinostat (f). Each symbol color combination indicates a different histotype

Back to article page